Blueprint Medicines Overview

Life ScienceCompany

Was Blueprint Medicines formerly PE-backed?

Yes. Blueprint Medicines was formerly owned by 2 private investors.

Where is Blueprint Medicines headquartered?

Blueprint Medicines is headquartered in Cambridge, Massachusetts.

What is Blueprint Medicines’ revenue?

Blueprint Medicines disclosed revenue of 509M USD for 2024 and 249M USD for 2023.

How many employees does Blueprint Medicines have?

Blueprint Medicines has 649 employees.

What sector is Blueprint Medicines in?

Blueprint Medicines is a life science company.

When was Blueprint Medicines founded?

Blueprint Medicines was founded in 2008.

Blueprint Medicines

Blueprint Medicines Corp.

45 Sidney Street,
Cambridge, Massachusetts 02139
United States,
(617) 374-7580
www.blueprintmedicines.com

Blueprint Medicines is a bio pharmaceutical company focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation. Blueprint Medicines was founded in 2008 and is based in Cambridge, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - 1 - - - - 1
vol $250M $250M
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Financial Deals
Goldman Sachs
1
Legal Deals
Goodwin Procter
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.